Recently, ATM and ATR inhibitors are highlighted as antitumor agents because numerous cancers, including CRC, utilize the ATM/ATR‐associated DDR for survival and drug resistance.26, 27, 28, 29, 30. The gene discussed is ATR; the disease is colorectal carcinoma.